NDUFA13

Chr 19

NADH:ubiquinone oxidoreductase subunit A13

Also known as: B16.6, CDA016, CGI-39, GRIM-19, GRIM19, MC1DN28

This gene encodes a subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), which functions in the transfer of electrons from NADH to the respiratory chain. The protein is required for complex I assembly and electron transfer activity. The protein binds the signal transducers and activators of transcription 3 (STAT3) transcription factor, and can function as a tumor suppressor. The human protein purified from mitochondria migrates at approximately 16 kDa. Transcripts originating from an upstream promoter and capable of expressing a protein with a longer N-terminus have been found, but their biological validity has not been determined. [provided by RefSeq, Oct 2009]

ResearchGenerating clinical summary…
MultiplemechanismLOEUF 1.77
Clinical SummaryNDUFA13
🧬
Gene-Disease Validity (ClinGen)
Leigh syndrome · ARModerate

Moderate evidence — consider for supplementary testing

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
7 unique Pathogenic / Likely Pathogenic· 54 VUS of 104 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.77LOEUF
pLI 0.000
Z-score -0.15
OE 1.06 (0.621.77)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.90Z-score
OE missense 1.26 (1.091.47)
121 obs / 96.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?1.06 (0.621.77)
00.351.4
Missense OE?1.26 (1.091.47)
00.61.4
Synonymous OE?1.24
01.21.6
LoF obs/exp: 8 / 7.5Missense obs/exp: 121 / 96.1Syn Z: -1.19

This gene — mechanism propensity

DN
0.6841th %ile
GOF
0.73top 25%
LOF
0.2968th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

104 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic4
VUS54
Likely Benign29
Benign4
Conflicting2
3
Pathogenic
4
Likely Pathogenic
54
VUS
29
Likely Benign
4
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
2
0
0
3
Likely Pathogenic
3
1
0
0
4
VUS
4
46
4
0
54
Likely Benign
0
0
12
17
29
Benign
0
1
2
1
4
Conflicting
2
Total850181896

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

8 pathogenic / likely-pathogenic (of 11) ClinVar copy-number / structural variants overlap NDUFA13 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

NDUFA13 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →